Lymphoid organs’ metabolism and its role in predicting the outcomes of patients with malignant melanoma treated with immunotherapy: an exploratory study-Reference-Cited by-同舟云学术

Lymphoid organs’ metabolism and its role in predicting the outcomes of patients with malignant melanoma treated with immunotherapy: an exploratory study

Published:2024-02-13 Issue:2 Volume:12 Page:213-223
ISSN:2281-7565
Container-title:Clinical and Translational Imaging
language:en
Short-container-title:Clin Transl Imaging

Author:

De Rimini Maria Luisa,Bianchi Andrea,Annovazzi Alessio,D’Arienzo Davide,Valente Tullio,Sciuto Rosa,Di Traglia Silvia,Nappi Anna Giulia,Ferrari Cristina,Rubini Giuseppe,Panareo Stefano,Urso Luca,Bartolomei Mirco,Aricò Demetrio,Bombaci Michelangelo,Caponnetto Domenica,Gusella Sara,Spimpolo Alessandro,Carriere Cinzia,Balma Michele,Buschiazzo Ambra,Gallicchio Rosj,Storto Giovanni,Filippi Luca,Evangelista Laura^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40336-023-00614-z.pdf

Reference18 articles.

1. Hodi FS, O’Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB et al (2010) Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363:711–723

2. Robert C, Schachter J, Long GV, Arance A, Grob JJ, Mortier L et al (2015) Pembrolizumab versus Ipilimumab in advanced melanoma. N Engl J Med 372:2521–2532

3. Tan AC, Emmett L, Lo S, Liu V, Kapoor R, Carlino MS et al (2018) FDG-PET response and outcome from anti-PD-1 therapy in metastatic melanoma. Ann Oncol Off J Eur Soc Med Oncol 29:2115–2120

4. Seban R-D, Nemer JS, Marabelle A, Yeh R, Deutsch E, Ammari S et al (2019) Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics. Eur J Nucl Med Mol Imaging 46:2298–2310

5. Saadani H, Aalbersberg EA, Schats W, Hoekstra OS, Stokkel MPM, de Vet HCW (2022) Comparing [18F]FDG PET/CT response criteria in melanoma and lung cancer patients treated with immunotherapy: a systematic review. Clin Transl Imaging 10:643–661